Sino Biopharmaceutical (01177) said its profit attributable owners of the parent for the six months ended 30 June 2016 rose 8.7% year-on-year to HK$1,009 million.
Basic and diluted earnings per share were HK13.61 cents.
The revenue was HK$8,039.9 million, an increase of 8% from a year earlier. Gross profit grew 10.4% year-on-year to HK$6,334 million.
The company will pay a second quarterly dividend of HK1.5 cents (2015: HK1.5 cents) per share for the three months ended 30 June 2016, which will be paid on 29 September 2016.